韦朝晗，助理教授，于2021年获华中科技大学工学博士学位，同年10月继续于华中科技大学从事博士后研究，2025年3月加入深圳大学医学部生物医学工程学院进行科研和教学工作。主要从事仿生纳米材料、肿瘤免疫治疗等相关研究。近五年，在Nature Communications、Advanced Materials、Signal Transduction and Targeted Therapy、Journal of Controlled Release、Chemical Engineering Journal等国际期刊发表论文18篇；主持国家自然科学基金青年项目、中国博士后科学基金面上资助各一项。

1.仿生纳米材料

2.肿瘤免疫治疗

1.国家自然科学基金青年科学基金项目，82203061，2023.01~2024.12，20万元，结题，主持

2.中国博士后科学基金面上资助，2022M721260，2022.10~2023.10，8万元，结题，主持

3.国家重点研发计划“纳米前沿”专项，2022YFA1206000，2023.01~2027.12，2475.20万元，在研，参与

4.国家自然科学基金面上项目，82272844，2023.01~2026.12，52万元，在研，参与

1.Zhaohan Wei#, Xiaoqiong Zhang#, Tuying Yong, Nana Bie, Guiting Zhan, Xin Li, Qingle Liang, Jianye Li, Jingjing Yu, Gang Huang, Yuchen Yan, Zelong Zhang, Bixiang Zhang, Lu Gan*, Bo Huang*, Xiangliang Yang*. Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles. Nature Communications, 2021, 12(1): 440

2.Zhaohan Wei#, Xiaoqiong Zhang#, Zelong Zhang#, Tuying Yong, Guiting Zhan, Weilin Lv, Ziqiao Ding, Kaili Sun, Xiangliang Yang*, Lu Gan*. Engineered iron-based nanoplatform amplifies repolarization of M2-like tumor-associated macrophages for enhanced cancer immunotherapy. Chemical Engineering Journal, 2022, 433: 133847

3. Xiaoqiong Zhang#,Zhaohan Wei#, Tuying Yong#, Shiyu Li, Nana Bie, Jianye Li, Xin Li, Haojie Liu, Hang Xu, Yuchen Yan, Bixiang Zhang, Xiaoping Chen, Xiangliang Yang*, Lu Gan*. Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem like CD8+ T cells to boost anti-PD-1 therapy. Nature Communications, 2023, 14(1): 5653

4. Nana Bie#, Tuying Yong#,Zhaohan Wei#, Qingle Liang, Xiaoqiong Zhang, Shiyu Li, Xin Li, Jianye Li, Lu Gan*, Xiangliang Yang*. Tumor-repopulating cell-derived microparticles elicit cascade amplification of chemotherapy-induced antitumor immunity to boostanti-PD-1 therapy. Signal Transduction and Targeted Therapy, 2023, 8(1): 408

5. Xiaoqiong Zhang#,Zhaohan Wei#, Ziqiao Ding, Weilin Lv, Jianye Li, Xin Li, Haojie Liu, Panli Yu, Xiangliang Yang*, Lu Gan*. Boosting doxil-based chemoimmunotherapy via reprogramming tumor-associated macrophages. Chemical Engineering Journal, 2023, 451:138971

6. Tuying Yong#,Zhaohan Wei#, Lu Gan*, Xiangliang Yang. Extracellular-vesicle-based drug delivery systems for enhanced antitumor therapies through modulating the cancer-immunity cycle. Advanced Materials, 2022, 34(52): 2201054

7. Tuying Yong#, Xin Li#,Zhaohan Wei#, Lu Gan*, Xiangliang Yang*. Extracellular vesicles-based drug delivery systems for cancer immunotherapy. Journal of Controlled Release, 2020, 328: 562-574